Leonardo Rojas - Concepedia

Author

Leonardo Rojas

Foundation for Clinical and Applied Cancer Research ORCID

Also Known As

L Rojas, L. Rojas, L.L. Rojas, LEONARDO ROJAS, Leonardo ROJAS, Leonardo Rojas, Liliana Guzman Rojas, Luis Leonardo Rojas Puentes, Lyda Yiced Machuca Rojas, Martín Ignacio Zapata

140

Publications

911

Citations

H-Index

Concepts

All Affiliations

Foundation for Clinical and Applied Cancer Research Instituto Nacional de Cancerología Universidad El Bosque Instituto Alexander Fleming Fundación Universitaria Sanitas

About

Leonardo Rojas is an author at Foundation for Clinical and Applied Cancer Research specializing in medicine, pathology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	324
2	Pathology	7	7	281
3	Cell Biology	2	2	110
4	Immunology	1	1	12
5	Neurology	1	1	43

Leonardo Rojas

Publications

609

Citations

H-Index

Page 1

	Year	Citations
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis Niki Karachaliou, Imane Chaib, Andrés F. Cardona, EBioMedicine Common Co-activationMedicinePathologyBronchial NeoplasmCancer Biology	2018	77
EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP) Andrés F. Cardona, Leonardo Rojas, Zyanya Lucía Zatarain-Barrón, Lung Cancer Tumor BiologyMedicinePathologyBronchial NeoplasmMolecular Oncology	2018	60
Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP) Alejandro Ruíz-Patiño, Óscar Arrieta, Andrés F. Cardona, Thoracic Cancer	2019	60
Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma Andrés F. Cardona, Leonardo Rojas, Beatriz Wills, Journal of Neuro-Oncology Neuro-oncologyMedicineHispanic PatientsOther Antiepileptic DrugsPsychotropic Medication	2017	43
Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation Andrés F. Cardona, Daniel Jaramillo-Velásquez, Alejandro Ruíz-Patiño, Journal of Neuro-Oncology Egfrviii MutationNeuro-oncologySimultaneous Egfr AmplificationOncologyGlioma	2021	43
An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP) Luis Corrales, Óscar Arrieta, Luís Más, Lung Cancer Cancer EpidemiologyAdvanced Lung DiseaseMedicineSmoking Related Lung DiseasePathology	2017	33
EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP) Alejandro Ruíz-Patiño, Christian David Castro, Luisa Ricaurte, Targeted Oncology MedicinePathologySensitizing Mutations CorrelateBronchial NeoplasmCancer Genomics	2018	33
Molecular Epidemiology of <b><i>ALK</i></b> Rearrangements in Advanced Lung Adenocarcinoma in Latin America Óscar Arrieta, Andrés F. Cardona, Guillermo F. Bramuglia, Oncology	2018	30
Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib Andrés F. Cardona, Alejandro Ruíz-Patiño, Zyanya Lucía Zatarain-Barrón, PLoS ONE	2019	29
Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP) Andrés F. Cardona, Leonardo Rojas, Zyanya Lucía Zatarain-Barrón, Frontiers in Oncology	2019	26

Page 1